ADC-Cytotoxin-Inhibitors-Modulators-MCE.docx 免費(fèi)下載
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、 HYPERLINK https:/www.MedChemE/Targets/ADC Cytotoxin.html ADC HYPERLINK https:/www.MedChemE/Targets/ADC Cytotoxin.html HYPERLINK https:/www.MedChemE/Targets/ADC Cytotoxin.html CytotoxinADC PayloadADC cytotoxins (also known as payloads) are cytotoxic agents that induce target cell death in Antibody D
2、rug Conjugates (ADCs). AnADC is a targeted agent composed with a monoclonal antibody, a linker and a cytotoxin. The cytotoxin is the most importantcomponent as it determines the potency to kill cancer cells of an ADC.There are many cytotoxins which are currently being used such as Calicheamicins, Du
3、ocarmycins, Pyrrolobenzodiazepines (PBDs),Camptothecins, Daunorubicins/Doxorubicins, Auristatins and Maytansinoids. They can be divided in two classes based on theirmechanism of action, DNA damaging agents and tubulin inhibitors. Among them Calicheamicins, Duocarmycins and PBDs are DNAminor grove bi
4、nders, Camptothecins and Daunorubicins/Doxorubicins are topoisomerase inhibitors, which are DNA damagingagents. Auristatins and Maytansinoids are tubulin inhibitors. Except for the listed cytotoxins, there are numbers of traditionalcytotoxic agents with similar mechanisms of killing cancer cells and
5、 can also be used in the development of ADCs.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/ADC Cytotoxin.html ADC HYPERLINK https:/www.MedChemE/Targets/ADC Cytotoxin.html HYPERLINK https:/www.MedChemE/Targets/ADC Cytotoxin.html Cytotoxin HYPERLINK https:/www.MedChemE/cbi-cdpi1.html (+)-CBI-CD
6、PI1 HYPERLINK https:/www.MedChemE/cbi-cdpi1.html HYPERLINK https:/www.MedChemE/cbi-cdpi2.html (+)-CBI-CDPI2Cat. No.: HY-128880 Cat. No.: HY-128881(+)-CBI-CDPI1 is an enhanced functional analog ofCC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent.(+)-CBI-CDPI1 is an antibody drug conjugates(ADCs) toxin
7、.(+)-CBI-CDPI2 is an enhanced functional analog ofCC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent.(+)-CBI-CDPI2 is an antibody drug conjugates(ADCs) toxin.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK htt
8、ps:/www.MedChemE/s-seco-duocarmycin-sa.html (S)-Seco-Duocarmycin HYPERLINK https:/www.MedChemE/s-seco-duocarmycin-sa.html HYPERLINK https:/www.MedChemE/s-seco-duocarmycin-sa.html SACat. No.: HY-129356A HYPERLINK https:/www.MedChemE/10-deacetyl-7-xylosyl-paclitaxel.html 10-Deacetyl-7-xylosyl HYPERLIN
9、K https:/www.MedChemE/10-deacetyl-7-xylosyl-paclitaxel.html HYPERLINK https:/www.MedChemE/10-deacetyl-7-xylosyl-paclitaxel.html paclitaxel HYPERLINK https:/www.MedChemE/10-deacetyl-7-xylosyl-paclitaxel.html (10-Deacetyl-7-xylosyltaxol;10-Deacetylpaclitaxel 7-Xyloside; ) Cat. No.: HY-20584(S)-Seco-Du
10、ocarmycin SA is a DNA alkylator,cytotoxic to cancer cells, and acts as a ADCcytotoxin for antibody-drug conjugates.10-Deacetyl-7-xylosyl paclitaxel is a Paclitaxel(a microtubule stabilizing agent; enhances tubulinpolymerization) derivative with improvedpharmacological features.Purity: 99.0%Clinical
11、Data: No Development ReportedSize: 5 mgPurity: 98.19%Clinical Data: No Development ReportedSize: 10 mg, 50 mg HYPERLINK https:/www.MedChemE/17-aep-ga.html 17-AEP-GA HYPERLINK https:/www.MedChemE/17-aep-ga.html HYPERLINK https:/www.MedChemE/17-gmb-apa-ga.html 17-GMB-APA-GACat. No.: HY-133570 Cat. No.
12、: HY-13099717-AEP-GA, an HSP90 antagonist, is a potentinhibitor of glioblastoma cell proliferation,survival, migration and invasion. ADCs Toxin.17-GMB-APA-GA is an ADC Cytotoxin. 17-GMB-APA-GAis a potent HSP90 inhibitor and used for latentT. gondii infection research.Purity: 98%Clinical Data: No Dev
13、elopment ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/2-3-cgamp-c2-sh.html 2,3-cGAMP-C2-SH HYPERLINK https:/www.MedChemE/2-3-cgamp-c2-sh.html HYPERLINK https:/www.MedChemE/7-aminomethyl-10-methyl-11-fluoro-camptothecin.html 7
14、-Aminomethyl-10-methyl-11-fluoro HYPERLINK https:/www.MedChemE/7-aminomethyl-10-methyl-11-fluoro-camptothecin.html HYPERLINK https:/www.MedChemE/7-aminomethyl-10-methyl-11-fluoro-camptothecin.html camptothecinCat. No.: HY-141663 Cat. No.: HY-1321602,3-cGAMP-C2-SH is a ADC cytotoxin that isextracted
15、from patent US20210015941, example 24.7-Aminomethyl-10-methyl-11-fluoro camptothecin isa cytotoxin ofMC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin(HY-132158compound 21a).Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development Rep
16、ortedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/7-mad-mdcpt.html 7-MAD-MDCPT HYPERLINK https:/www.MedChemE/7-mad-mdcpt.html HYPERLINK https:/www.MedChemE/aeruginosin-865.html Aeruginosin HYPERLINK https:/www.MedChemE/aeruginosin-865.html HYPERLINK https:/www.MedChemE/aeruginosin-865.html 865Cat.
17、 No.: HY-132162 Cat. No.: HY-1309947-MAD-MDCPT, a Camptothecin analog, is a toxinpayload in antibody drug conjugates (ADCs).Aeruginosin 865, isolated from terrestrialcyanobacterium Nostoc sp. Lukeov 30/93, is thefirst aeruginosin-type peptide containing both afatty acid and a carbohydrate moiety. Ae
18、ruginosin865 inhibits translocation of NF-kB to thenucleus.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/agrochelin.htm
19、l AgrochelinCat. No.: HY-130995 HYPERLINK https:/www.MedChemE/INNO-206.html Aldoxorubicin(INNO-206; DOXO-EMCH) Cat. No.: HY-16261Agrochelin, an alkaloid cytotoxic antibiotic, isproduced by the fermentation of a marineAgrobacterium sp. Agrochelin has cytotoxicactivity in tumor cell lines.Aldoxorubici
20、n (INNO-206) is an albumin-bindingprodrug of Doxorubicin (DNA topoisomerase IIinhibitor), which is released from albumin underacidic conditions. Aldoxorubicin (INNO-206) haspotent antitumor activities in various cancer celllines and in murine tumor models.Purity: 98%Clinical Data: No Development Rep
21、ortedSize: 5 mg, 10 mg, 25 mgPurity: 95.99%Clinical Data: Phase 3Size: 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/aminohexylgeldanamycin.html Aminohexylgeldanamycin(AHGDM) Cat. No.: HY-133571 HYPERLINK https:/www.MedChemE/aminohexylgeldanamycin-hydrochloride.html Aminohexylgeldanamycin
22、 HYPERLINK https:/www.MedChemE/aminohexylgeldanamycin-hydrochloride.html HYPERLINK https:/www.MedChemE/aminohexylgeldanamycin-hydrochloride.html hydrochloride(AHGDM hydrochloride) Cat. No.: HY-133571AAminohexylgeldanamycin (AHGDM), a Geldanamycinderivative, is a potent HSP90 inhibitor.Aminohexylgeld
23、anamycin shows antiangiogenic andantitumor activities.Aminohexylgeldanamycin (AHGDM) hydrochloride, aGeldanamycin derivative, is a potent HSP90inhibitor. Aminohexylgeldanamycin hydrochlorideshows antiangiogenic and antitumor activities.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10
24、mg, 25 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/aniline-mpb-amino-c3-pbd.html Aniline-MPB-amino-C3-PBDCat. No.: HY-135900 HYPERLINK https:/www.MedChemE/Ansamitocin-P-3_acute_.html Ansamitocin HYPERLINK https:/www.MedChemE/Ansamitocin-P-3_acute
25、_.html HYPERLINK https:/www.MedChemE/Ansamitocin-P-3_acute_.html P HYPERLINK https:/www.MedChemE/Ansamitocin-P-3_acute_.html HYPERLINK https:/www.MedChemE/Ansamitocin-P-3_acute_.html 3(Antibiotic C 15003P3; Maytansinol butyrate) Cat. No.: HY-19839Aniline-MPB-amino-C3-PBD is a cytotoxic agentcomprise
26、d non-alkylating group.Aniline-MPB-amino-C3-PBD is a sequence-selectiveDNA minor-groove binding agent.Aniline-MPB-amino-C3-PBD acts as the payload forADCs. Antimicrobial activity.Ansamitocin P 3 exhibits antitumour activity, isan antibody drug conjugate cytotoxin. The moreinformation please refer to
27、 Ansamitocin P-3(HY-15739, a tubulin inhibitor).Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/Ansamitocin-P-3.html Ansamitocin HYPERLINK https:/
28、www.MedChemE/Ansamitocin-P-3.html HYPERLINK https:/www.MedChemE/Ansamitocin-P-3.html P-3 HYPERLINK https:/www.MedChemE/Ansamitocin-P-3.html HYPERLINK https:/www.MedChemE/Auristatin-E.html Auristatin HYPERLINK https:/www.MedChemE/Auristatin-E.html HYPERLINK https:/www.MedChemE/Auristatin-E.html E(Ant
29、ibiotic C 15003P3; Maytansinol isobutyrate) Cat. No.: HY-15739Cat. No.: HY-15582Ansamitocin P-3 (Antibiotic C 15003P3) is amicrotubule inhibitor. Ansamitocin P-3 is amacrocyclic antitumor antibiotic.Auristatin E is a cytotoxic tubulin modifier withpotent and selective antitumor activity; MMAEanalog
30、and cytotoxin in Antibody-drug conjugates.Auristatin E inhibits cell division by blockingthe polymerisation of tubulin.Purity: 98.0%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.36%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 50 mg, 10
31、0 mg HYPERLINK https:/www.MedChemE/Auristatin-F.html Auristatin HYPERLINK https:/www.MedChemE/Auristatin-F.html HYPERLINK https:/www.MedChemE/Auristatin-F.html F HYPERLINK https:/www.MedChemE/Auristatin-F.html HYPERLINK https:/www.MedChemE/azonafide-peaba.html Azonafide-PEABACat. No.: HY-15583 Cat.
32、No.: HY-126664Auristatin F is a potent cytotoxin. Auristatin F, apotent microtubule inhibitor and vasculardamaging agent (VDA), can be used in antibody-drugconjugates (ADC).Azonafide-PEABA is a cytotoxic drug moiety.Purity: 99.11%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mgPurity: 9
33、8%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/c-11.html C-11Cat. No.: HY-100861 HYPERLINK https:/www.MedChemE/Calicheamicin.html Calicheamicin(Calicheamicin 1) Cat. No.: HY-19609C-11 is a tubulin inhibitor and acts as an ADCcytotoxin, displays c
34、ytotoxicity for carcinoma celllines.Calicheamicin, an antitumor antibiotic, is acytotoxic agent that causes double-strand DNAbreaks. Calicheamicin is a DNA synthesisinhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.28%Clinical Data: No Development ReportedSize: 1
35、mg, 5 mg HYPERLINK https:/www.MedChemE/Campathecin.html Camptothecin(Campathecin; (S)-(+)-Camptothecin; CPT) Cat. No.: HY-16560 HYPERLINK https:/www.MedChemE/camptothecin-d5.html Camptothecin-d5(Campathecin-d5; (S)-(+)-Camptothecin-d5; CPT-d5) Cat. No.: HY-16560SCamptothecin (CPT), a kind of alkaloi
36、d, is a DNAtopoisomerase I (Topo I) inhibitor with an IC of50679 nM.Camptothecin-d5 (Campathecin-d5) is the deuteriumlabeled Camptothecin. Camptothecin (CPT), a kindof alkaloid, is a DNA topoisomerase I (Topo I)inhibitor with an IC of 679 nM.50Purity: 99.69%Clinical Data: LaunchedSize: 10 mM 1 mL, 1
37、00 mg, 500 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/cc-885-ch2-peg1-nh-ch3.html CC-885-CH2-PEG1-NH-CH3 HYPERLINK https:/www.MedChemE/cc-885-ch2-peg1-nh-ch3.html HYPERLINK https:/www.MedChemE/corixetan.html CorixetanCat. No.: HY-145449 Cat. No.
38、: HY-132851CC-885-CH2-PEG1-NH-CH3 is a neoDegrader that canbe used in the synthesis of Antibody neoDegraderConjugate (AnDC).Corixetan is a highly efficient thorium chelator.Corixetan can efficiently complex Th-227 withsufficient in vivo stability.Purity: 98%Clinical Data: No Development ReportedSize
39、: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/D8-MMAF.html D8-MMAF HYPERLINK https:/www.MedChemE/D8-MMAF.html HYPERLINK https:/www.MedChemE/daun02.html Daun02(Monomethylauristatin F D8) Cat. No.: HY-15579SCat. No.: HY-13061D8-MMAF hydroch
40、loride is a deuterated form of MMAFhydrochloride. MMAF Hydrochloride, a potenttubulin polymerization inhibitor, is used as aantitumor agent and a cytotoxic component ofantibody-drug conjugates (ADCs).Daun02 is a prodrug of the topoisomeraseinhibitor Daunorubicin.Purity: 98%Clinical Data: No Developm
41、ent ReportedSize: 1 mg, 5 mgPurity: 98.85%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/daunorubicin.html Daunorubicin HYPERLINK https:/www.MedChemE/daunorubicin.html HYPERLINK https:/www.MedChemE/Daunorubicin-Hydrochloride.html Daunorubicin
42、HYPERLINK https:/www.MedChemE/Daunorubicin-Hydrochloride.html HYPERLINK https:/www.MedChemE/Daunorubicin-Hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/Daunorubicin-Hydrochloride.html (Daunomycin hydrochloride; RP(Daunomycin; RP 13057; Rubidomycin) Cat. No.: HY-13062A 13057 hydrochlo
43、ride; Rubidomycin hydrochloride) Cat. No.: HY-13062Daunorubicin (Daunomycin; RP 13057; Rubidomycin)is a topoisomerase II inhibitor with potentantineoplastic activities. Daunorubicin(Daunomycin; RP 13057; Rubidomycin) inhibits DNAand RNA synthesis in sensitive and resistantEhrlich ascites tumor cells
44、.Daunorubicin (Daunomycin) hydrochloride is atopoisomerase II inhibitor with potentantineoplastic activities. Daunorubicinhydrochloride inhibits DNA and RNA synthesis insensitive and resistant Ehrlich ascites tumorcells.Purity: 98%Clinical Data: LaunchedSize: 5 mg, 10 mg, 25 mgPurity: 99.23%Clinical
45、 Data: LaunchedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg4 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/dc0-nh2.html DC0-NH2 HYPERLINK https:/www.MedChemE/dc0-nh2.html HYPERLINK https:/www.MedChemE/DC1.html DC1Cat. No.: HY-129379 Cat. No.: HY-112
46、899DC0-NH2 is an effector moiety for ADC and asimplified analog of DC1 with better stability.DC0-NH2 is about 1000-fold more cytotoxic thancommonly used anticancer drugs (ex. Doxorubicin).DC1, an analogue of the minor groove-binding DNAalkylator CC-1065, is a ADC Cytotoxin. DC1 can beused in synthes
47、is of antibody-drug conjugates forthe targeted treatment of cancer.Purity: 95.21%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mgPurity: 98%Clinical Data: Phase 2Size: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dc10sme.html DC10SMe HYPERLINK https:/www.MedChemE/dc10sme.html HY
48、PERLINK https:/www.MedChemE/DC1-SMe.html DC1SMeCat. No.: HY-135122 Cat. No.: HY-112898DC10SMe is a DNA alkylator, can be used in thesynthesis of Antibody-drug Conjugate (ADC).DC10SMe exhibits IC s of 15 pM, 12 pM, and 12 pM50for Ramos, Namalwa, and HL60/s cancer cells,respectively.DC1Sme, a DC1 deri
49、vative, exhibits IC values of5022 pM, 10 pM, 32 pM and 250 pM for Ramos, Namalwa,HL60/s and COLO 205 cancer cells, respectively.DC1, an analogue of the minor groove-binding DNAalkylator CC-1065, is a ADC Cytotoxin.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.0%Clinical
50、 Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/dc4.html DC4 HYPERLINK https:/www.MedChemE/dc4.html HYPERLINK https:/www.MedChemE/dc41.html DC41Cat. No.: HY-135125 Cat. No.: HY-112901DC4, an ADC cytotoxin, can be used in thesynthesis of
51、 Antibody-drug Conjugate (ADC). DC4can be used for the targeted treatment of cancer.DC41 is a DC1 derivative. DC1, a simplifiedanalogue of CC-1065, is an antibody conjugate ofcytotoxic DNA alkylators for the targetedtreatment of cancer.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 m
52、gPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dc41-sme.html DC41SMe HYPERLINK https:/www.MedChemE/dc41-sme.html HYPERLINK https:/www.MedChemE/dc44sme.html DC44SMeCat. No.: HY-112900 Cat. No.: HY-135124DC41SMe, a DC1 derivative, shows cytotoxicity in
53、Ramos, Namalwa, and HL60/s cells with IC s50ranging from 18-25 pM. DC1, a simplified analogueof CC-1065, is an antibody conjugate of cytotoxicDNA alkylators for the targeted treatment ofcancer.DC44SMe, a phosphate prodrug of cytotoxic DNAalkylator DC44, can be used in the synthesis ofAntibody-drug C
54、onjugate (ADC). DC44SMe exhibitsIC s of 2.0 nM, 2.8 nM, and 1.9 nM for Ramos,50Namalwa, and HL60/s cancer cells, respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dc4sme.html D
55、C4SMe HYPERLINK https:/www.MedChemE/dc4sme.html HYPERLINK https:/www.MedChemE/diacetyl-agrochelin.html Diacetyl HYPERLINK https:/www.MedChemE/diacetyl-agrochelin.html HYPERLINK https:/www.MedChemE/diacetyl-agrochelin.html AgrochelinCat. No.: HY-135123 Cat. No.: HY-130996DC4SMe, a phosphate prodrug o
56、f cytotoxic DNAalkylator DC4, can be used in the synthesis ofAntibody-drug Conjugate (ADC). DC4SMe exhibitsIC s of 1.9 nM, 2.9 nM, and 1.8 nM for Ramos,50Namalwa, and HL60/s cancer cells, respectively.Diacetyl Agrochelin is an acetyl derivative ofAgrochelin, which is produced by the fermentationof a
57、 marine Agrobacterium sp. DiacetylAgrochelin has cytotoxic activity in tumor celllines.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mgwww.MedChemE 5 HYPERLINK https:/www.MedChemE/dimethyl-sgd-1882.html Dimethy
58、l-SGD-1882(Dimethyl-PBD dimer) Cat. No.: HY-126678 HYPERLINK https:/www.MedChemE/dm1-sme.html DM1-SMeCat. No.: HY-100128Dimethyl-SGD-1882 (Dimethyl-PBD dimer) is a highlypotent DNA alkylator, and is used as anantibody-drug conjugate (ADC) cytotoxin. PBD Dimeris a DNA alkylator which inhibits DNA rep
59、lication.DM1-SMe is an unconjugated form of theMaytansinoid in IMGN901. DM1-SMe is about3-10-fold more potent than the parent drugMaytansine, with IC s ranging from 0.003 to 0.0150nM for DM1-SMe in a panel of human tumor celllines.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPuri
60、ty: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dm3.html DM3(Maytansinoid DM3) Cat. No.: HY-130080 HYPERLINK https:/www.MedChemE/dm3-sme.html DM3-SMeCat. No.: HY-130081DM3 (Maytansinoid DM3) is a maytansine analogbearing disulfide or thiol groups and a tub
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 罕見病診斷思維訓(xùn)練的模擬教學(xué)案例庫更新機(jī)制
- 2026屆海南省文昌華僑中學(xué)語文高三第一學(xué)期期末經(jīng)典試題含解析
- 罕見病藥物研發(fā)中的成本控制策略
- 罕見病藥物可及性的社會(huì)共付模式
- 新聞生產(chǎn)傳播流程制度
- 造船展示活動(dòng)策劃方案(3篇)
- 領(lǐng)導(dǎo)視察活動(dòng)策劃方案(3篇)
- 2025年山西崇安能源發(fā)展有限公司招聘筆試真題
- 2025年楚雄州教育體育局直屬學(xué)校選調(diào)工作人員筆試真題
- 罕見病抗凝治療出血并發(fā)癥的防治策略
- 2025年國家能源局系統(tǒng)公務(wù)員面試模擬題及備考指南
- 脊柱感染護(hù)理
- 2025年安徽省中考化學(xué)真題及答案
- 危險(xiǎn)品押運(yùn)證考試題及答案
- 2025年黨建工作應(yīng)試題庫及答案
- 痤瘡皮膚護(hù)理常規(guī)
- 2025-2030中國自動(dòng)分板設(shè)備自動(dòng)PCB分板設(shè)備行業(yè)運(yùn)行態(tài)勢與投資前景預(yù)測報(bào)告
- 2025年陜西省中考英語試卷(含解析)
- 2025至2030中國海綿新材料行業(yè)市場發(fā)展現(xiàn)狀及商業(yè)模式與投資發(fā)展報(bào)告
- 《三級醫(yī)院評審標(biāo)準(zhǔn)(2025年版)》
- 急診成人社區(qū)獲得性肺炎臨床實(shí)踐指南(2024 年版)解讀
評論
0/150
提交評論